There were no pharmaceutical manufacturing facilities in Pakistan at the time of independence in 1947, so it had to heavily rely on imports to meet its healthcare needs. Over time, in response to the local demand, the pharmaceutical industry developed and has grown to a size of about US$ 3 billion, with exports worth roughly $200 million as of 2017. Currently, about 60,000 registered medicines are manufactured in Pakistan by approximately 650 companies, including 30 multinationals. The regulatory oversight and logistical infrastructure, on the other hand, has not kept up the pace. Inefficiencies in the procurement of medicines have severely affected the supply security, safety, and quality of medicines with various instances of expired medicines being sold to unsuspecting patients. With a growing population and life expectancy, the strain on the supply chain system is only expected to exacerbate. It is clear that there are fundamental issues in quality management and integrity across the country.
​
Bluestone Healthcare Services ("Bluestone") hopes to address these problems by setting higher quality and ethical standards for the industry that our people will stand behind and advocate. Bluestone’s vision for the future is based on improving efficiencies through digital transformation and allowing for economies of scale. The company’s management and leadership team includes a depth of specialization across business management, finance, medicine, government, and technology to provide a deep level of business competencies. Leveraging a diverse set of skills and ideas is critical in capturing and applying vital healthcare data, and a key part of Bluestone's strategy to optimize the healthcare supply chain. We aim to leverage data analytics and cutting-edge technology to determine trends in supply and demand, reducing the need for excess medication to be produced, and work to support supply-demand models with effective and algorithm-derived logistics systems. Using healthcare data analytics to drive down costs and bring improvements in healthcare infrastructure will be a primary focus for Bluestone as it addresses significant gaps that exist in healthcare delivery and management.
​
Further, Bluestone aims to take a broader, holistic view by providing not just medicine but helping improve the healthcare industry by introducing better practices. We hope to go beyond traditional supply chain management and work with various industry and community stakeholders to inspire a new era of wellness.
About the Company
Mission
-
Our goal is to provide health-related products using state of the art technology and industry best practices.
-
Continually improve the quality of life across Pakistan as the main pioneering force to inspire a new era of wellness.
Core Values
-
Passion
-
Caring
-
Integrity
-
Fairness
Aim & Objectives
-
Inventory​: Introduce smart asset management to medicines and equipment to control and maintain inventory.
-
Distribution​: Streamline ordering, payments, and distribution to facilitate uniform access to medication.​
-
Compliance​: Exceed regulatory requirements to introduce a new level of standards.
Scope
-
Create a Business-to-Business (B2B) model that allows for wholesale distribution by purchasing medicines, supplies and equipment from manufacturers and selling to healthcare institutions.
-
Expand into the Business-to-Consumers (B2C) market by purchasing medicines and supplies from manufacturers and selling directly to patients